Transcriptome analysis of mice brain chronically infected with Toxoplasma gondii and validation of the kynurenine pathway associated with depression

doi:10.12140/j.issn.1000-7423.2023.03.002

Abstract

Abstract:

Objective To screen the differentially expressed genes (DEGs) by comparing the transcriptome of the brain tissues between the mice chronically infected with Toxoplasma gondii and normal mice, to analyze the relative transcription level of DEGs in the depression-related kynurenine (KYN) pathway and to provide a theoretical basis for exploring the mechanism of depression-like symptoms caused by Toxoplasma gondii chronic infecttion in mice. Methods SV129 male mice (n = 18) were randomly and equally divided into the infection group and the control group. Mice in the infection group were intraperitoneally injected with 120 tachyzoites of T. gondii ME49 strain (200 μl), and mice in the control group were injected with the same volume of PBS. After 3 months post-infection, mice brain tissues of the two groups were collected for extraction of total RNA to undertake transcriptome sequencing for screening DEG. With the DEGs obtained, cluster analysis, gene ontology (GO) functional annotation analysis, Kyoto Encyclopedia of Genes and Genomes (KEGG) functional annotation and enrichment analysis were performed. Eight DEGs [interferon-γ (IFN-γ), indoleamine 2,3-dioxygenase 1 (IDO1), IDO2, kynurenine-3-monooxygenase (KYNU), kynurenine-3-monooxygenase (KMO), 3-hydroxyanthranilate 3,4-dioxygenase (3-HAO), vimentin (Vim) and brain-derived neurotrophic factor (BDNF)] related to KYN pathway associated with depression were selected to examine each gene’s relative transcription level by quantitative real-time PCR (qRT-PCR), using glyceraldehyde-3-phosphate dehydrogenase gene as an internal reference. Results Transcriptome sequencing found 2 295 DEGs in the brain of the mice from the infection and control groups, of which 2 016 were up-regulated and 279 were down-regulated. GO analysis showed that localisation was the most significantly enriched biological process, with a total of 257 DEGs. The most significantly enriched in cellular components was the protein-containing complex, with a total of 425 DEGs. The most significantly enriched molecular function was molecular transducer activity, with 177 DEGs. The largest number of DEGs enriched in biological process, cell component and molecular function were cell process, cell part and binding, with 1 039, 1 240 and 1 088 DEGs, respectively. KEGG analysis showed that the top three up-regulated metabolic pathways were the immune system, signaling transduction, and viral infectious disease, and the top three down-regulated pathways were signal transduction, signaling molecules and interaction and immune system. Functional enrichment analysis showed that 77 pathways were significantly enriched. The signaling pathways related to depression include tumor necrosis factor signaling pathway, neuroactive ligand-receptor interaction, NF-kappa B signaling pathway, JAK-STAT signaling pathway, necroptosis, apoptosis, chemokine signaling pathway, KYN pathway. The qRT-PCR results showed that the relative transcription levels of IFN-γ, IDO1, IDO2, KYNU, KMO, 3-HAO and Vim genes in the infection group were 3 023.08%, 355.52%, 190.17%, 496.55%, 339.92%, 212.74% and 507.34%, if the relative transcript level of control mice was taken as 100%. Compared with the control group, the transcription was significantly up-regulated (t = 3.782, 3.749, 3.226, 2.908, 2.533, 5.656, 2.948; all P < 0.05 or 0.01). The relative transcription level of BDNF was 63.32%, which was significantly down-regulated (t = 2.398, P < 0.05). The fold change of IFN-γ, IDO1, IDO2, KYNU, KMO, 3-HAO, BDNF, Vim obtained by qRT-PCR was 4.96, 1.74, 0.89, 2.10, 1.60, 1.06, -0.94, 2.18, respectively. The fold change obtained by transcriptome sequencing was 7.30, 0.55, 0.80, 3.83, 2.75, 3.53, -0.86 and 1.93, respectively. The transcriptional trend obtained by qRT-PCR was consistent with that obtained by transcriptome sequencing. Conclusion DEGs from brain tissues of mice chronically infected with T. gondii were screened. Transcriptome analysis revealed that the immune response of central nervous system of the mice with chronic infection of T. gondii was continuously activated. Seven DEGs in KYN pathway related to depression showed up-regulated transcription level.

Key words: Toxoplasma gondii, Mice brain tissue, Transcriptome, Depression, Kynurenine pathway

CLC Number:

R382.5

ZHANG Chi, CHEN Jiating, XIN Zixuan, YANG Lili, YANG Zihan, PENG Hongjuan. Transcriptome analysis of mice brain chronically infected with Toxoplasma gondii and validation of the kynurenine pathway associated with depression[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2023, 41(3): 270-278.

Figures/Tables 6

Table 1

Table 2

Fig. 1

Fig. 2

Fig. 3

Fig. 4

References 41

[1]	Elsheikha HM, Marra CM, Zhu XQ. Epidemiology, pathophysiology, diagnosis, and management of cerebral toxoplasmosis[J]. Clin Microbiol Rev, 2020, 34(1): e00115-e00119.
[2]	Robert-Gangneux F, Dardé ML. Epidemiology of and diagnostic strategies for toxoplasmosis[J]. Clin Microbiol Rev, 2012, 25(2): 264-296.
[3]	Luft BJ, Conley F, Remington JS, et al. Outbreak of central-nervous-system toxoplasmosis in western Europe and North America[J]. Lancet, 1983, 1(8328): 781-784.
[4]	Henriquez SA, Brett R, Alexander J, et al. Neuropsychiatric disease and Toxoplasma gondii infection[J]. Neuroimmunomodulation, 2009, 16(2): 122-133.
[5]	Hsu PC, Groer M, Beckie T. New findings: depression, suicide, and Toxoplasma gondii infection[J]. J Am Assoc Nurse Pract, 2014, 26(11): 629-637
[6]	Parlog A, Schlüter D, Dunay IR. Toxoplasma gondii-induced neuronal alterations[J]. Parasite Immunol, 2015, 37(3): 159-170.
[7]	Pape K, Tamouza R, Leboyer M, et al. Immunoneuropsychiatry-novel perspectives on brain disorders[J]. Nat Rev Neurol, 2019, 15(6): 317-328.
[8]	Ferrari AJ, Charlson FJ, Norman RE, et al. Burden of depressive disorders by country, sex, age, and year: findings from the global burden of disease study 2010[J]. PLoS Med, 2013, 10(11): e1001547.
[9]	Ruderfer DM, Walsh CG, Aguirre MW, et al. Significant shared heritability underlies suicide attempt and clinically predicted probability of attempting suicide[J]. Mol Psychiatry, 2020, 25(10): 2422-2430.
[10]	Wittenberg GM, Greene J, Vértes PE, et al. Major depressive disorder is associated with differential expression of innate immune and neutrophil-related gene networks in peripheral blood: a quantitative review of whole-genome transcriptional data from case-control studies[J]. Biol Psychiatry, 2020, 88(8): 625-637.
[11]	Kitaoka S. Inflammation in the brain and periphery found in animal models of depression and its behavioral relevance[J]. J Pharmacol Sci, 2022, 148(2): 262-266.
[12]	Innes S, Pariante CM, Borsini A. Microglial-driven changes in synaptic plasticity: a possible role in major depressive disorder[J]. Psychoneuroendocrinology, 2019, 102: 236-247.
[13]	Li BJ, Yang W, Ge TT, et al. Stress induced microglial activation contributes to depression[J]. Pharmacol Res, 2022, 179: 106145.
[14]	Sochocka M, Diniz BS, Leszek J. Inflammatory response in the CNS: friend or foe?[J]. Mol Neurobiol, 2017, 54(10): 8071-8089.
[15]	Xu C, Zhang LD. Research advances of kynurenine pathway in depressive disorder[J]. Mil Med J Southeast China, 2022, 24(1): 69-72. (in Chinese)
	(徐畅, 张利东. 犬尿氨酸代谢通路在抑郁症中的研究进展[J]. 东南国防医药, 2022, 24(1): 69-72.)
[16]	Jeon SW, Kim YK. Inflammation-induced depression: its pathophysiology and therapeutic implications[J]. J Neuroimmunol, 2017, 313: 92-98.
[17]	Sforzini L, Nettis MA, Mondelli V, et al. Inflammation in cancer and depression: a starring role for the kynurenine pathway[J]. Psychopharmacology, 2019, 236(10): 2997-3011.
[18]	Su WJ, Cao ZY, Jiang CL. Inflammatory mechanism of depression and its new strategy for diagnosis and treatment[J]. Acta Physiol Sin, 2017, 69(5): 715-722. (in Chinese)
	(苏文君, 曹志永, 蒋春雷. 抑郁症的炎症机制及诊疗新策略[J]. 生理学报, 2017, 69(5): 715-722.)
[19]	Sa QL, Mercier C, Cesbron-Delauw MF, et al. The amino-terminal region of dense granule protein 6 of Toxoplasma gondii stimulates IFN-γ production by microglia[J]. Microbes Infect, 2020, 22(8): 375-378.
[20]	MacKenzie CR, Heseler K, Müller A, et al. Role of indoleamine 2, 3-dioxygenase in antimicrobial defence and immuno-regulation: tryptophan depletion versus production of toxic kynurenines[J]. Curr Drug Metab, 2007, 8(3): 237-244.
[21]	Cheng JH, Xu X, Li YB, et al. Arctigenin ameliorates depression-like behaviors in Toxoplasma gondii-infected intermediate hosts via the TLR4/NF-κB and TNFR1/NF-κB signaling pathways[J]. Int Immunopharmacol, 2020, 82: 106302.
[22]	Lan HW, Lu YN, Zhao XD, et al. New role of sertraline against Toxoplasma gondii-induced depression-like behaviours in mice[J]. Parasite Immunol, 2021, 43(12): e12893.
[23]	Jiang ZH, Zhou X, Li R, et al. Whole transcriptome analysis with sequencing: methods, challenges and potential solutions[J]. Cell Mol Life Sci, 2015, 72(18): 3425-3439.
[24]	Dubey JP, Laurin E, Kwowk OC. Validation of the modified agglutination test for the detection of Toxoplasma gondii in free-range chickens by using cat and mouse bioassay[J]. Parasitology, 2016, 143: 314-319.
[25]	Li SY, He B, Yang CH, et al. Comparative transcriptome analysis of normal and CD44-deleted mouse brain under chronic infection with Toxoplasma gondii[J]. Acta Trop, 2020, 210: 105589.
[26]	Pittman KJ, Aliota MT, Knoll LJ. Dual transcriptional profiling of mice and Toxoplasma gondii during acute and chronic infection[J]. BMC Genomics, 2014, 15(1): 806.
[27]	He JJ, Ma J, Li FC, et al. Transcriptional changes of mouse splenocyte organelle components following acute infection with Toxoplasma gondii[J]. Exp Parasitol, 2016, 167: 7-16.
[28]	Tanaka S, Nishimura M, Ihara F, et al. Transcriptome analysis of mouse brain infected with Toxoplasma gondii[J]. Infect Immun, 2013, 81(10): 3609-3619.
[29]	Smith K. Mental health: a world of depression[J]. Nature, 2014, 515(7526): 181.
[30]	De-Miguel FF, Trueta C. Synaptic and extrasynaptic secretion of serotonin[J]. Cell Mol Neurobiol, 2005, 25(2): 297-312.
[31]	Salamone JD, Ecevitoglu A, Carratala-Ros C, et al. Complexities and paradoxes in understanding the role of dopamine in incentive motivation and instrumental action: exertion of effort vs. anhedonia[J]. Brain Res Bull, 2022, 182: 57-66.
[32]	Pariante CM, Lightman SL. The HPA axis in major depression: classical theories and new developments[J]. Trends Neurosci, 2008, 31(9): 464-468.
[33]	Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression[J]. Trends Neurosci, 2013, 36(5): 305-312.
[34]	Diviccaro S, Giatti S, Borgo F, et al. Treatment of male rats with finasteride, an inhibitor of 5 alpha-reductase enzyme, induces long-lasting effects on depressive-like behavior, hippocampal neurogenesis, neuroinflammation and gut microbiota composition[J]. Psychoneuroendocrinology, 2019, 99: 206-215.
[35]	Suda K, Matsuda K. How microbes affect depression: underlying mechanisms via the gut-brain axis and the modulating role of probiotics[J]. Int J Mol Sci, 2022, 23(3): 1172.
[36]	Martinowich K, Manji H, Lu B. New insights into BDNF function in depression and anxiety[J]. Nat Neurosci, 2007, 10(9): 1089-1093.
[37]	Sakamoto S, Zhu XL, Hasegawa Y, et al. Inflamed brain: targeting immune changes and inflammation for treatment of depression[J]. Psychiatry Clin Neurosci, 2021, 75(10): 304-311.
[38]	Innes S, Pariante CM, Borsini A. Microglial-driven changes in synaptic plasticity: a possible role in major depressive disorder[J]. Psychoneuroendocrinology, 2019, 102: 236-247.
[39]	Li BJ, Yang W, Ge TT, et al. Stress induced microglial activation contributes to depression[J]. Pharmacol Res, 2022, 179: 106145.
[40]	Ogyu K, Kubo K, Noda Y, et al. Kynurenine pathway in depression: a systematic review and meta-analysis[J]. Neurosci Biobehav Rev, 2018, 90: 16-25.
[41]	Egan CE, Cohen SB, Denkers EY. Insights into inflammatory bowel disease using Toxoplasma gondii as an infectious trigger[J]. Immunol Cell Biol, 2012, 90(7): 668-675.

基因名称 Gene name	GenBank登录号 GenBank accession No.	引物序列（5'→3'） Primer sequence (5'→3')
甘油醛-3-磷酸脱氢酶 Glyceraldehyde-3-phosphate dehydrogenase	NM_008084.4	F: AGGTCGGTGTGAACGGATTTG R: TGTAGACCATGTAGTTGAGGTCA
γ-干扰素 Interferon-gamma	NM_008337.4	F: GCCACGGCACAGTCATTGA R: TGCTGATGGCCTGATTGTCTT
吲哚胺2,3-双加氧酶1 Indoleamine 2,3-dioxygenase 1	NM_008324.3	F: GCCTCCTATTCTGTCTTATGCAG R: ATACAGTGGGGATTGCTTTGATT
吲哚胺2,3-双加氧酶2 Indoleamine 2,3-dioxygenase 2	NM_145949.2	F: TCAAAGTCAGAGCATGACGCT R: GGCGGTTCTCGATTAAGTGAG
犬尿氨酸酶 Kynureninase	NM_027552.3	F: GTCAAGCCTGCGTTAGTGG R: GGAGGGTTTGAAATTCGGAATCC
犬尿氨酸-3-单加氧酶 Kynurenine 3-monooxygenase	NM_133809.1	F: ATGGCATCGTCTGATACTCAGG R: AGCTTCGTACACATCAACTTGAA
3-羟邻氨苯甲酸加双氧酶 3-hydroxyanthranilate 3,4-dioxygenase	NM_025325.2	F: GAACGCCGTGTGAGAGTGAA R: CCAACGAACATGATTTTGAGCTG
脑源性神经营养因子 Brain derived neurotrophic factor	NM_001048141.1	F: TTACCTGGATGCCGCAAACAT R: TGACCCACTCGCTAATACTGTC
波形蛋白 Vimentin	NM_011701.4	F: TCCACACGCACCTACAGTCT R: CCGAGGACCGGGTCACATA

样品 Sample	过滤后序列 Clean reads	有效碱基数 Clean bases	质量值≥ 30的碱基占比/% Q30/%	GC含量/% GC content/%	比对序列总数（总比对率/%） Total mapped reads（Total mapped rate/%）	唯一比对序列数（唯一比对率/%） Uniquely mapped reads（Uniquely mapped rate/%）
C1	60 348 640	8 633 462 674	95.43	51.57	57 807 295（95.79）	54 855 233（90.90）
C2	61 001 728	8 826 547 002	95.68	51.58	58 482 793（95.87）	55 704 439（91.32）
C3	47 872 426	7 054 290 403	93.07	51.34	45 777 160（95.62）	43 662 798（91.21）
I1	57 527 866	8 375 627 414	95.56	52.33	54 932 387（95.49）	52 527 951（91.31）
I2	65 226 576	9 504 352 717	95.59	51.74	62 245 261（95.43）	59 337 049（90.97）
I3	59 326 802	8 627 270 056	95.68	51.94	5 6301 394（94.90）	53 835 983（90.74）